Imatinib Completed Phase 2 Trials for Insulin-Dependent Diabetes Mellitus 1 / Type 1 Insulin-Dependent Diabetes Mellitus / Diabetes Mellitus, Insulin-Dependent, 1 Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01781975Imatinib Treatment in Recent Onset Type 1 Diabetes Mellitus